VRTX Jan 2024 120.000 put
| Previous close | 2.3000 |
| Open | 2.3000 |
| Bid | 0.6000 |
| Ask | 9.6000 |
| Strike | 120.00 |
| Expiry date | 2024-01-19 |
| Day's range | 2.3000 - 2.3000 |
| Contract range | N/A |
| Volume | |
| Open interest | 77 |
- Zacks
Vertex (VRTX) to Report Q4 Earnings: What's in the Cards?
On Vertex Pharmaceuticals' (VRTX) Q4 earnings call, investors will likely focus on the sales performance of its cystic fibrosis medicines and updates on its non-CF pipeline candidates.
- Motley Fool
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
Last year's bear market made many victims among even the most prominent corporations although growth stocks fared even worse than other categories of equities. Among this small group of outperformers are two healthcare leaders: biotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) and medical device expert DexCom (NASDAQ: DXCM). Let's consider why Vertex Pharmaceuticals and DexCom are excellent stocks to buy.
- Zacks
Ultragenyx (RARE) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Ultragenyx (RARE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
